|Bid||0.5815 x 0|
|Ask||0.6163 x 0|
|Day's Range||0.5777 - 0.5779|
|52 Week Range||0.2823 - 4.4000|
|Beta (5Y Monthly)||1.67|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OTTAWA, July 23, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch its line of vape products to both adult-use and medical consumers, across Canada. “At HEXO, we pride ourselves in ensuring our consumers have access to high-quality, reliable and consistent cannabis products,” said Sebastien St. Louis, CEO and co-founder of HEXO Corp. “We are thrilled to launch our vape products across Canada as we continue to focus on innovation and launching additional 2.0 products across all of our brands.”Prior to releasing its line of vapes, the Company conducted testing to evaluate the taste, tolerability of effects and short-term undesired effects of its proprietary terpene blends.HEXO’s vape products currently include three ready-to-use vape pens and four 510-thread cartridges, in popular strain-inspired terpene blends. HEXO vapes are available across Canada to both adult-use and medical consumers.About HEXO CorpHEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.Investor Relations: invest@HEXO.com www.hexocorp.comMedia Relations: (819) 317-0526 email@example.com
U.S.-listed shares of Hexo Corp. shot up 18% in premarket trading Thursday, after the Canada-based cannabis company said it will start selling medical cannabis in Israel, marking the first time its medical cannabis products will be available outside of Canada. The sales in Israel will be through a 24-month agreement with Israeli medical cannabis company Breath of Life International Ltd. The company said it completed the first shipment of 493 kilograms. Hexo's flower products will be available to patients in Israel packaged in a 10-gram format. "The products are already receiving positive feedback from both patients and retailers, and we are looking forward to continuing to expand our strategic relationship with HEXO in Israel," said Hugo Goldman, interim chief executive of Breath of Life. Hexo's stock has dropped 56.3% year to date through Wednesday, while the Cannabis ETF has lost 22.2% and the S&P 500 has slipped 1.9%.
OTTAWA, July 09, 2020 -- HEXO Corp (TSX: HEXO; NYSE: HEXO) (“HEXO” or the “Company”) is proud to announce that it has launched medical cannabis products in Israel through a.